Bilatu
7-tik 1-7 emaitza erakusten
Dementia related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
(Dove Medical Press Limitedprevalence, 2019)
Background: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant
of family stress and institutionalization of patients. This study aimed to identify inequalities
by gender and socioeconomic status ...
Validation of Random Forest Machine Learning Models to Predict Dementia-Related Neuropsychiatric Symptoms in Real-World Data
(IOS Press, 2020)
Background: Neuropsychiatric symptoms (NPS) are the leading cause of the social burden of dementia but their role is underestimated.
Objective: The objective of the study was to validate predictive models to separately ...
Disparities by socioeconomic status and diagnosis of dementia in the prescribing of antipsychotics in a real-World data population over 60 years of age
(IOS Press, 2024)
Background:
Antipsychotics are widely used in the elderly due to the high prevalence of neuropsychiatric associated with dementia.
Objective:
To analyze potential disparities in antipsychotic use in the general ...
Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer's disease
(BioMed Central Ltd. Part of Springer Nature, 2020)
Background: The LipiDiDiet trial showed that Souvenaid, a medical food, might delay progression to dementia in prodromal Alzheimer’s disease (AD). The objective of this study was to assess the cost-utility of Souvenaid ...
Estimation of the epidemiology of dementia and associated neuropsychiatric symptoms by applying machine learning to real-world data
(Elsevier, 2022)
Introduction
Incidence rates of dementia-related neuropsychiatric symptoms (NPS) are not known and this hampers the assessment of their population burden. The objective of this study was to obtain an approximate estimate ...
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain
(Springer Nature, 2022)
Introduction
The effectiveness, safety, and cost-effectiveness of the use of Souvenaid for Alzheimer’s disease (AD) have been previously evidenced. To complete the economic analysis, there is a need to assess whether ...
Comorbidity and household income as mediators of gender inequalities in dementia risk: a real-world data population study
(Springer Nature, 2024)
Comorbidity and low HI act as mediators in the increased risk of dementia associated with female sex. Given the difference in the prevalence of comorbidities by HI, individual interventions to control comorbidities could ...
